Recall of substandard Erythromycin batch

The Drug Administration Department requests 120 Armepharco Co., Ltd. to send recall notices to wholesale, retail, and end-user establishments of the Erythromycin 500 mg film-coated tablet batch number VD-31437-19 with an expiration date of June 15, 2028.

Today, February 28th, the Drug Administration Department ( Ministry of Health ) issued official document No. to the health departments of provinces and cities and 120 Armepharco Co., Ltd. announcing the recall of drugs with level 2 violations.

The Drug Administration announces the recall of a batch of substandard drugs.

The Drug Administration of Vietnam announces the nationwide recall of Erythromycin 500 mg film-coated tablets (Erythromycin 500 mg), Registration Number: VD-31437-19; Batch Number: 022024, Manufacturing Date: June 15, 2024, Expiry Date: June 15, 2028, manufactured by 120 Armepharco Co., Ltd.

The Drug Administration Department requests that 120 Armepharco Co., Ltd. coordinate with the drug distributor to send recall notices to wholesale, retail, and end-user establishments of the aforementioned Erythromycin 500 mg film-coated tablets and recall the entire batch of substandard drugs; and submit a recall report to the Drug Administration Department within 18 days from the date of signing the official letter.

The Drug Administration Department requests that provincial health departments and health agencies notify businesses and users of the recalled batch of substandard drugs mentioned above, inspect and monitor units implementing this notification, and handle units that violate regulations according to current laws.

At the same time, we request the Hanoi Department of Health to inspect and supervise 120 Armepharco Co., Ltd. in carrying out the recall and handling of the recalled drugs in accordance with regulations.

Previously, the Drug Administration received a report from the Central Institute for Drug Testing regarding the results of supplementary sampling of a batch of Erythromycin 500mg film-coated tablets, batch number: 022024, manufacturing date: June 15, 2024, expiry date: June 15, 2028, which failed to meet quality standards regarding quantitative analysis. This batch of medicine was determined to be in violation at level 2.

According to information from the treatment unit, Erythromycin is a prescription antibiotic used to treat certain bacterial infections.

Source: https://thanhnien.vn/thu-hoi-lo-thuoc-erythromycin-khong-dat-chat-luong-185250228200004818.htm